GT Biopharma's total assets for Q3 2025 were $4.32M, a decrease of -39.35% from the previous quarter. GTBP total liabilities were $1.32M for the fiscal quarter, a -42.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.